Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00104169 · ClinicalTrials.gov registry record · Phase 2
Idiopathic Anemia of Aging (IAA)
A Phase 2 study, sponsored by National Institute on Aging (NIA).
- Terminated
- Registry status
- Phase 2
- Development phase
NCT00104169: Clinical Trial Phase 2 study, sponsored by National Institute on Aging (NIA).
NCT00104169 is a Phase 2 study that was terminated before completion, run by National Institute on Aging (NIA). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00104169, a Phase 2 study, was terminated before completion, sponsored by National Institute on Aging (NIA).
- TERMINATED
- Registry status
- Phase 2
- Development phase
Study Summary
The purpose of this trial is to examine whether Epoetin Alfa, a hormone stimulating production of red blood cells, can reverse idiopathic anemia.
Interventions
- DRUG Epoetin Alfa
Trial Details
| Field | Value |
|---|---|
| Start Date | 2004-08 |
| Est. Completion | 2007-05 |
| Phase | Phase 2 |
Why NCT00104169 stopped before completion
NCT00104169 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Epoetin Alfa is the first listed.
NCT00104169 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00104169 about?
NCT00104169 is a clinical study titled "Idiopathic Anemia of Aging (IAA)". The purpose of this trial is to examine whether Epoetin Alfa, a hormone stimulating production of red blood cells, can reverse idiopathic anemia.
What is the current status of trial NCT00104169?
This trial is currently terminated. It is a Phase 2 study. The study started on 2004-08. Estimated completion is 2007-05.
What interventions are being tested in trial NCT00104169?
The interventions under investigation include: Epoetin Alfa (DRUG).
Who is sponsoring clinical trial NCT00104169?
This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia